Possible association between different congenital abnormalities and use of different sulfonamides during pregnancy

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Congenital Anomalies

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1741-4520.2004.00012.xPMID 15198720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Maternal drug use in early pregnancy and infant cardiovascular defect.

  2003cited by this paper
• Validation studies of drug exposures in pregnant women

  2003cited by this paper
• Folic acid antagonists during pregnancy and risk of birth defects.

  2001cited by this paper
• Description and mission evaluation of the Hungarian case-control surveillance of congenital abnormalities, 1980-1996.

  2001cited by this paper
• Recall Bias in a Case-Control Surveillance System on the Use of Medicine during Pregnancy

  2001cited by this paper
• The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study.

  2001cited by this paper
• Folic acid antagonists during pregnancy and the risk of birth defects.

  2000cited by this paper
• Occurrence of congenital heart defects in relation to maternal mulitivitamin use.

  2000cited by this paper
• Occurrence of Congenital Heart Defects in Relation to Maternal Multivitamin Use

  2000cited by this paper
• Multivitamin supplementation and risk of birth defects.

  1999cited by this paper
• First 25 years of the Hungarian congenital abnormality registry.

  1997influential reference
• Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based, case-control study.

  1996cited by this paper
• Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation.

  1996cited by this paper
• Ebsteins malformation Genetic and environmental factors

  1994cited by this paper
• Epidemiologic characteristics of phenotypically distinct neural tube defects among 0.7 million California births, 1983-1987.

  1994cited by this paper
• Prevention of congenital abnormalities by periconceptional multivitamin supplementation.

  1993cited by this paper
• Goodman and Gilman's The Pharmacological Basis of Therapeutics

  1986cited by this paper
• Birth defects and drugs in pregnancy

  1977cited by this paper
• Clinical Aspects of the Teratogenicity of Drugs

  1976cited by this paper
• Associations between oral clefts and drugs taken during pregnancy.

  1975cited by this paper
• Associations between Drugs Administered during Pregnancy and Congenital Abnormalities of the Fetus

  1971cited by this paper
• AROMATIC DRUGS AND CONGENITAL CATARACTS.

  1964cited by this paper
• Abnormalities of pulmonary and other vessels in rat fetuses from maternal pteroylglutamic acid deficiency

  1963cited by this paper
• “Bimez” and Teratogenic Action

  1963cited by this paper
• Maternal and Newborn Distribution and Excretion of Sulfamethoxypyridazine (Kynex)

  1958cited by this paper
• Maternal and newborn distribution and excretion of sulfamethoxypyridazine (kynex).

  1958cited by this paper
• Congenital Cardiovascular Anomalies Induced by Pteroylglutamic Acid Deficiency during Gestation in the Rat

  1954cited by this paper
• Esophageal atresia with tracheosophageal fistula; epidemiologic and teratologic implications.

  1949cited by this paper
• Esophageal Atresia with Tracheoesophageal Fistula

  1949cited by this paper
• Placental transmission of sulfathiazole and sulfadiazine and its significance for fetal chemotherapy

  1943cited by this paper
• CHEMOTHERAPY DURING PREGNANCY: DANGER OF FETAL INJURY FROM SULFANILAMIDE AND ITS DERIVATIVES

  1941cited by this paper
• The Placental Transfer of Sulfanilamide

  1938cited by this paper

• Microbiome-generated antifolates.

  2026cites this paper
• First-Trimester Antibiotic Use for Urinary Tract Infection and Risk of Congenital Malformations

  2025cites this paper
• Are the Diagnosis and Treatment of Acute Cystitis in the Premenopausal, Pregnant, and Postmenopausal Women the Same? A Review of the Literature

  2022cites this paper
• Environmental Exposures and Congenital Heart Disease.

  2021cites this paper
• Teratogen update: Malaria in pregnancy and the use of antimalarial drugs in the first trimester

  2020cites this paper
• Maternal exposure to sulfonamides and adverse pregnancy outcomes: A systematic review and meta-analysis

  2020cites this paper
• Risk factors associated with congenital defects that alter hearing or vision in children born in the city of Bogotá between 2002 and 2016.

  2019cites this paper
• Maternal Use of Antibacterial or Antifungal Drugs for Systemic Use and Infant Congenital Malformations

  2019cites this paper
• Animal Embryotoxicity Studies of Key Non‐Artemisinin Antimalarials and Use in Women in the First Trimester

  2017cites this paper
• Committee Opinion No. 717: Sulfonamides, Nitrofurantoin, and Risk of Birth Defects.

  2017cites this paper
• Proportion of selected congenital heart defects attributable to recognized risk factors.

  2016cites this paper
• Trimethoprim–sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies

  2016cites this paper
• Assessment of Potential Risk Factors for Congenital Anomalies in Low Risk population at tertiary care hospital

  2016cites this paper
• Insights into the genetics of clubfoot

  2015cites this paper
• Findings from the National Birth Defects Prevention Study: Interpretation and translation for the clinician.

  2015cites this paper
• Investigation of gene specific DNA methylation and folate polymorphisms and their relevance for human health and disease.

  2015cites this paper
• Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity

  2014cites this paper
• Folate Deficiency and Folic Acid Supplementation: The Prevention of Neural-Tube Defects and Congenital Heart Defects

  2013cites this paper
• IDENTIFYING GENETIC VARIANTS AND CHARACTERIZING THEIR ROLE IN CLUBFOOT

  2012cites this paper
• Periconceptional Folic Acid-Containing Multivitamin Supplementation for the Prevention of Neural Tube Defects and Cardiovascular Malformations

  2011cites this paper
• Association of drug treatments in pregnant women with the risk of external ear congenital abnormalities in their offspring: A population‐based case‐control study

  2011cites this paper
• Folic Acid/Folic Acid-Containing Multivitamins and Primary Prevention of Birth Defects and Preterm Birth

  2010cites this paper
• For more information about the Organization of Teratology Information

  2010cites this paper
• Interaction between genetics and environment in the development of clubfoot

  2010cites this paper
• The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology

  2009cites this paper
• Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study.

  2009cites this paper
• Possible association between acute pelvic inflammatory disease in pregnant women and congenital abnormalities in their offspring: a population-based case-control study.

  2008cites this paper
• Maternal urinary tract infections and selected cardiovascular malformations.

  2008cites this paper
• Safety and Toxicity of Sulfadoxine/Pyrimethamine

  2007cites this paper
• Dermatologic treatment during pregnancy: how to weigh the risk:benefit ratio for mother and fetus

  2007cites this paper
• Population‐based case‐control teratogenic study of hydroxyprogesterone treatment during pregnancy

  2006cites this paper
• Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings.

  2006cites this paper
• Population‐based case‐control study of oxoline acid use during pregnancy for birth outcomes

  2006cites this paper
• Risk and Benefit of Drug Use During Pregnancy

  2005cites this paper
• Drug exposure in pregnant women

  2004cites this paper